1. Home
  2. LYRA vs SOHO Comparison

LYRA vs SOHO Comparison

Compare LYRA & SOHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LYRA
  • SOHO
  • Stock Information
  • Founded
  • LYRA 2005
  • SOHO 2004
  • Country
  • LYRA United States
  • SOHO United States
  • Employees
  • LYRA N/A
  • SOHO N/A
  • Industry
  • LYRA Medical/Dental Instruments
  • SOHO Real Estate Investment Trusts
  • Sector
  • LYRA Health Care
  • SOHO Real Estate
  • Exchange
  • LYRA Nasdaq
  • SOHO Nasdaq
  • Market Cap
  • LYRA 15.0M
  • SOHO 15.4M
  • IPO Year
  • LYRA 2020
  • SOHO 2004
  • Fundamental
  • Price
  • LYRA $9.15
  • SOHO $0.89
  • Analyst Decision
  • LYRA Buy
  • SOHO Hold
  • Analyst Count
  • LYRA 2
  • SOHO 1
  • Target Price
  • LYRA $16.00
  • SOHO $1.50
  • AVG Volume (30 Days)
  • LYRA 288.0K
  • SOHO 44.0K
  • Earning Date
  • LYRA 08-13-2025
  • SOHO 08-12-2025
  • Dividend Yield
  • LYRA N/A
  • SOHO N/A
  • EPS Growth
  • LYRA N/A
  • SOHO N/A
  • EPS
  • LYRA N/A
  • SOHO N/A
  • Revenue
  • LYRA $1,185,000.00
  • SOHO $182,158,199.00
  • Revenue This Year
  • LYRA N/A
  • SOHO $13.93
  • Revenue Next Year
  • LYRA $1,286.17
  • SOHO N/A
  • P/E Ratio
  • LYRA N/A
  • SOHO N/A
  • Revenue Growth
  • LYRA N/A
  • SOHO 3.11
  • 52 Week Low
  • LYRA $3.81
  • SOHO $0.59
  • 52 Week High
  • LYRA $37.50
  • SOHO $1.54
  • Technical
  • Relative Strength Index (RSI)
  • LYRA 44.26
  • SOHO 52.58
  • Support Level
  • LYRA $8.35
  • SOHO $0.94
  • Resistance Level
  • LYRA $9.36
  • SOHO $1.04
  • Average True Range (ATR)
  • LYRA 1.25
  • SOHO 0.09
  • MACD
  • LYRA -0.72
  • SOHO -0.01
  • Stochastic Oscillator
  • LYRA 9.95
  • SOHO 40.74

About LYRA Lyra Therapeutics Inc.

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

About SOHO Sotherly Hotels Inc.

Sotherly Hotels Inc is engaged in Hotel operations. The company is a self-managed and self-administered lodging real estate investment trust that was formed to own, acquire, renovate, and reposition full-service, upscale, and upper-upscale hotel properties located in primary markets in the mid-Atlantic and southern United States. It generates revenue through the rooms, food, beverage, and other services. Geographically, the group has its presence in the regions of Florida, Georgia, Indiana, Maryland, North Carolina, Pennsylvania, Texas, and Virginia.

Share on Social Networks: